Permanent Capital Management’s Pfizer PFE Stock Holding History

Permanent Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$229K	Buy	+9,465	New	+$261K	0.05%	129

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Permanent Capital Management's PFE Position: Q2 2024 in Review

Permanent Capital Management opened a new position in Pfizer (PFE) in Q2 2024: 9,465 shares worth $229K. The stake represents 0.05% of the portfolio and ranks #129 among its holdings.

2,874 funds tracked by Wall St. Rank hold PFE as of Q2 2024.

Permanent Capital Management held 9,465 shares of Pfizer worth $229K as of Q2 2024.
Pfizer was a new Permanent Capital Management position in Q2 2024.
Pfizer made up 0.05% of Permanent Capital Management's portfolio in Q2 2024, its #129 holding.
2,874 funds tracked by Wall St. Rank held Pfizer as of Q2 2024.

Based on Permanent Capital Management's 13F filing for Q2 2024, filed 15 Jul 2025.